-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Thymalfasin in Thymic Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Thymalfasin in Thymic Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thymalfasin in Thymic Carcinoma Drug Details: Thymalfasin (Zadaxin) is a synthetic...
-
Product Insights
Reproductive Health Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Reproductive Health Devices Pipeline Market Report Overview Endometrial ablation devices, female sterilization devices, reversible contraceptive devices, and assisted reproductive technology devices are the main categories of reproductive health devices. The reproductive health devices pipeline report provides comprehensive information about the main products with their comparative segment-wise analysis at various stages of development. The following are some of the key highlights of the reproductive health devices pipeline market: As of February 2024, the reversible contraceptive devices segment was the leading segment...
-
Product Insights
NewDyspepsia (Indigestion) – Drugs In Development, 2024
Empower your strategies with our Dyspepsia (Indigestion) – Drugs In Development, 2024 report and make more profitable business decisions. Indigestion is a group of gastrointestinal symptoms that occur together, including pain, a burning feeling, or discomfort in the upper abdomen; feeling full too soon while eating; and feeling uncomfortable after eating. Treatment for indigestion depends on the cause and may include medicines, changes in what you eat and drink, psychological therapies, and lifestyle changes. The Dyspepsia (Indigestion) drugs in development market...
-
Product Insights
NewFunctional (Non Ulcer) Dyspepsia – Drugs In Development, 2024
Empower your strategies with our Functional (Non Ulcer) Dyspepsia – Drugs In Development, 2024 report and make more profitable business decisions. Non-ulcer dyspepsia is a term used to describe signs and symptoms of indigestion that have no obvious cause. Non-ulcer dyspepsia is also called functional dyspepsia or non-ulcer stomach pain. Signs and symptoms include a burning sensation or discomfort in the upper abdomen or lower chest, sometimes relieved by food or antacids; bloating; belching; and nausea. The predisposing factors include excessive...
-
Product Insights
NewCorrosive Esophagitis (Erosive Esophagitis) – Drugs In Development, 2024
Empower your strategies with our Corrosive Esophagitis (Erosive Esophagitis) – Drugs In Development, 2024 report and make more profitable business decisions. Erosive esophagitis is the damage caused to the tissue lining. It occurs because of the reflux of gastric contents into the stomach leading to mucosal injury. It is otherwise called as corrosive esophagitis whichis the severe form of gastroesophageal reflux disease (GERD). The Corrosive Esophagitis (Erosive Esophagitis) drugs in development market research report provide comprehensive information on the therapeutics under...
-
Product Insights
NewDuodenal Ulcer – Drugs In Development, 2024
Empower your strategies with our Duodenal Ulcer – Drugs In Development, 2024 report and make more profitable business decisions. Duodenal ulcers, a subset of peptic ulcer disease, result from a disruption in the mucosal surface of the duodenum, the initial segment of the small intestine. The primary culprit behind this condition is infection with Helicobacter pylori (H. pylori) bacteria. H. pylori induces inflammation in the duodenal lining, leading to ulcer formation. Certain medications, especially anti-inflammatory drugs like ibuprofen and aspirin, can...
-
Product Insights
NewGastric Ulcers – Drugs In Development, 2024
Empower your strategies with our Gastric Ulcers – Drugs In Development, 2024 report and make more profitable business decisions. Gastric ulcer is a painful sore or ulcer in the lining of stomach. The most common cause of gastric ulcer is Helicobacter pylori bacterial infection. Symptoms include pain, bloating, retching, nausea or vomiting, and unexplained weight loss. Predisposing factors include smoking and alcoholism. Treatment includes antibiotics and antacids. The Gastric Ulcers drugs in development market research report provide comprehensive information on the...
-
Product Insights
NewPeptic Ulcers – Drugs In Development, 2024
Empower your strategies with our Peptic Ulcers – Drugs In Development, 2024 report and make more profitable business decisions. Peptic ulcers are open sores that develop on the inside lining of esophagus, stomach, and the upper portion of small intestine. Symptoms include nausea or vomiting, unexplained weight loss, appetite changes, and abdominal pain. Risk factors include smoking and alcoholism. Treatment includes antibiotics, acid blockers, antacids, and proton pump inhibitors. The Peptic Ulcers drugs in development market research report provide comprehensive information...
-
Product Insights
NewReflux Esophagitis (Gastroesophageal Reflux Disease) – Drugs In Development, 2024
Empower your strategies with our Reflux Esophagitis (Gastroesophageal Reflux Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Gastroesophageal reflux disease (GERD) refers to a condition where the liquid content of the stomach refluxes into the esophagus. It is a chronic condition. The symptoms of GERD are nausea, heartburn, and vomiting. The predisposing factors include eating large meals, which can cause the lower esophageal sphincter (LES) to open inappropriately, as well as obesity, pregnancy, greasy food, and...
-
Product Insights
NewEsophageal Diseases – Drugs In Development, 2024
Empower your strategies with our Esophageal Diseases – Drugs In Development, 2024 report and make more profitable business decisions. Esophageal Diseases, which are characterized by weakened muscles and narrowing of the esophageal opening, often lead to difficulties in digestion and swallowing. The esophagus is the tube-shaped muscle that connects the throat to the stomach. Esophageal diseases occur when the esophagus muscle and opening become weak. The most common problem with the esophagus is GERD (gastroesophageal reflux disease). With GERD, a muscle...